| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-89 |
Sentence |
denotes |
Characterization of a chloroquine-induced canine model of pruritus and skin inflammation. |
| T2 |
90-101 |
Sentence |
denotes |
BACKGROUND: |
| T3 |
102-242 |
Sentence |
denotes |
Chloroquine (CQ) is a prototypical systemic and intradermal pruritogen for histamine-independent (nonhistaminergic) itch in mice and humans. |
| T4 |
243-310 |
Sentence |
denotes |
The predictive validity of this model is poorly documented in dogs. |
| T5 |
311-332 |
Sentence |
denotes |
HYPOTHESIS/OBJECTIVE: |
| T6 |
333-404 |
Sentence |
denotes |
To determine pruritogenic and inflammatory effects of systemic and i.d. |
| T7 |
405-435 |
Sentence |
denotes |
CQ injections in healthy dogs. |
| T8 |
436-444 |
Sentence |
denotes |
ANIMALS: |
| T9 |
445-489 |
Sentence |
denotes |
Ten healthy purpose-bred laboratory beagles. |
| T10 |
490-512 |
Sentence |
denotes |
METHODS AND MATERIALS: |
| T11 |
513-640 |
Sentence |
denotes |
All dogs were randomized to receive i.d. (200 and 400 µg/site), intravenous (2 mg/kg) and subcutaneous (3 mg/kg) CQ injections. |
| T12 |
641-746 |
Sentence |
denotes |
Dogs were video-recorded for 30 min after i.d. injections and for 300 min after i.v. and s.c. injections. |
| T13 |
747-808 |
Sentence |
denotes |
Buffered saline injections served as controls for each route. |
| T14 |
809-900 |
Sentence |
denotes |
Global wheal scores were evaluated at 30 min post-i.d. injection by a blinded investigator. |
| T15 |
901-909 |
Sentence |
denotes |
RESULTS: |
| T16 |
910-1082 |
Sentence |
denotes |
All dogs showed wheal and erythema at the CQ i.d. injection sites; global wheal scores of each CQ concentration were significantly increased compared to placebo (P ≤ 0.05). |
| T17 |
1083-1228 |
Sentence |
denotes |
Blinded evaluation revealed no significant increase in generalized pruritic behaviour (pruritic seconds) after i.v. or s.c. administration of CQ. |
| T18 |
1229-1381 |
Sentence |
denotes |
Intradermal injections induced mild localized acute pruritic behaviours at the site of injections at 200 µg (P = 0.06) and 400 µg (P = 0.27) CQ in dogs. |
| T19 |
1382-1419 |
Sentence |
denotes |
CONCLUSION AND CLINICAL SIGNIFICANCE: |
| T20 |
1420-1505 |
Sentence |
denotes |
To the best of the authors' knowledge, this is the first report which shows that i.d. |
| T21 |
1506-1566 |
Sentence |
denotes |
CQ injections may induce acute inflammation in healthy dogs. |
| T22 |
1567-1772 |
Sentence |
denotes |
By contrast to the systemic CQ-induced pruritus reported previously in healthy mice and dogs, no significant pruritic behaviours were observed after CQ injection, regardless of the route of administration. |
| T1 |
0-89 |
Sentence |
denotes |
Characterization of a chloroquine-induced canine model of pruritus and skin inflammation. |
| T2 |
90-101 |
Sentence |
denotes |
BACKGROUND: |
| T3 |
102-242 |
Sentence |
denotes |
Chloroquine (CQ) is a prototypical systemic and intradermal pruritogen for histamine-independent (nonhistaminergic) itch in mice and humans. |
| T4 |
243-310 |
Sentence |
denotes |
The predictive validity of this model is poorly documented in dogs. |
| T5 |
311-332 |
Sentence |
denotes |
HYPOTHESIS/OBJECTIVE: |
| T6 |
333-404 |
Sentence |
denotes |
To determine pruritogenic and inflammatory effects of systemic and i.d. |
| T7 |
405-435 |
Sentence |
denotes |
CQ injections in healthy dogs. |
| T8 |
436-444 |
Sentence |
denotes |
ANIMALS: |
| T9 |
445-489 |
Sentence |
denotes |
Ten healthy purpose-bred laboratory beagles. |
| T10 |
490-512 |
Sentence |
denotes |
METHODS AND MATERIALS: |
| T11 |
513-640 |
Sentence |
denotes |
All dogs were randomized to receive i.d. (200 and 400 µg/site), intravenous (2 mg/kg) and subcutaneous (3 mg/kg) CQ injections. |
| T12 |
641-746 |
Sentence |
denotes |
Dogs were video-recorded for 30 min after i.d. injections and for 300 min after i.v. and s.c. injections. |
| T13 |
747-808 |
Sentence |
denotes |
Buffered saline injections served as controls for each route. |
| T14 |
809-900 |
Sentence |
denotes |
Global wheal scores were evaluated at 30 min post-i.d. injection by a blinded investigator. |
| T15 |
901-909 |
Sentence |
denotes |
RESULTS: |
| T16 |
910-1082 |
Sentence |
denotes |
All dogs showed wheal and erythema at the CQ i.d. injection sites; global wheal scores of each CQ concentration were significantly increased compared to placebo (P ≤ 0.05). |
| T17 |
1083-1228 |
Sentence |
denotes |
Blinded evaluation revealed no significant increase in generalized pruritic behaviour (pruritic seconds) after i.v. or s.c. administration of CQ. |
| T18 |
1229-1381 |
Sentence |
denotes |
Intradermal injections induced mild localized acute pruritic behaviours at the site of injections at 200 µg (P = 0.06) and 400 µg (P = 0.27) CQ in dogs. |
| T19 |
1382-1419 |
Sentence |
denotes |
CONCLUSION AND CLINICAL SIGNIFICANCE: |
| T20 |
1420-1505 |
Sentence |
denotes |
To the best of the authors' knowledge, this is the first report which shows that i.d. |
| T21 |
1506-1566 |
Sentence |
denotes |
CQ injections may induce acute inflammation in healthy dogs. |
| T22 |
1567-1772 |
Sentence |
denotes |
By contrast to the systemic CQ-induced pruritus reported previously in healthy mice and dogs, no significant pruritic behaviours were observed after CQ injection, regardless of the route of administration. |